Cohlhepp Ryan
SEC CIK 2034665 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Pres, COO, Interim CEO, Dir | 199.1K | — | $4.60M | 27 | 2025-10-06 | 2026-09-08 |
Most active insiders at BCAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $4.80M | — |
| 2 | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | — | $4.60M |
| 3 | Mazumdar Claire | CEO, Dir | — | $4.06M |
| 4 | Hyep Ivan | CFO | — | $3.24M |
| 5 | Raben David | Chief Medical Off | — | $1.15M |
| 6 | Meisner Lara | CLO | — | $498.7K |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-10 16:23 | 2026-09-08 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | M - OptEx | $3.79 | +17.5K | 199.1K | +10% | +$66.3K |
| DMT | 2026-09-10 16:23 | 2026-09-08 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | S - Sale+OE | $22.90 | -17.5K | 181.6K | -9% | -$400.7K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +18.8K | 200.4K | +10% | +$71.1K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $27.98 | -18.8K | 181.6K | -9% | -$524.5K |
| DT | 2026-07-10 16:10 | 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +18.8K | 210.4K | +10% | +$71.1K |
| DMT | 2026-07-10 16:10 | 2026-07-08+ | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $28.98 | -28.8K | 181.6K | -14% | -$833.1K |
| DT | 2026-05-18 16:24 | 2026-05-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 204.1K | +4% | +$30.3K |
| DMT | 2026-05-18 16:24 | 2026-05-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $20.29 | -12.5K | 191.6K | -6% | -$253.6K |
| DT | 2026-04-17 16:55 | 2026-04-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 208.6K | +4% | +$30.3K |
| DMT | 2026-04-17 16:55 | 2026-04-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $23.01 | -12.5K | 196.1K | -6% | -$287.6K |
| DM | 2026-03-17 | 2026-03-16 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $19.66 | -12.5K | 200.6K | -6% | -$245.8K |
| D | 2026-03-17 | 2026-03-16 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 213.1K | +4% | +$30.3K |
| DM | 2026-03-05 | 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.16 | -17.4K | 205.1K | -8% | -$315.8K |
| D | 2026-03-05 | 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +12.9K | 222.5K | +6% | +$48.9K |
| D | 2026-02-27 | 2026-02-25 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +3,108 | 213.3K | +1% | +$11.8K |
| DM | 2026-02-27 | 2026-02-25 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.04 | -3,631 | 209.6K | -2% | -$65.5K |
| 2026-01-26 | 2026-01-22 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale | $18.10 | -3,828 | 210.2K | -2% | -$69.3K | |
| 2026-01-20 | 2026-01-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale | $18.02 | -149 | 214.0K | -0.1% | -$2,685 | |
| D | 2025-12-29 | 2025-12-26 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $4.44 | +25.0K | 214.1K | +13% | +$111.0K |
| DM | 2025-12-16 | 2025-12-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.68 | -12.5K | 193.6K | -6% | -$233.5K |
| D | 2025-12-16 | 2025-12-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 201.6K | +4% | +$30.3K |
| D | 2025-11-25 | 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 206.1K | +4% | +$30.3K |
| DM | 2025-11-25 | 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.05 | -12.5K | 198.1K | -6% | -$225.6K |
| DM | 2025-10-16 | 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.16 | -12.5K | 198.1K | -6% | -$227.0K |
| D | 2025-10-16 | 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 210.6K | +4% | +$30.3K |
| DM | 2025-10-08 | 2025-10-06+ | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.06 | -50.5K | 221.1K | -19% | -$912.0K |
| DM | 2025-10-08 | 2025-10-06+ | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +32.0K | 245.1K | +15% | +$121.3K |
Purchase Sale Sale after option exercise All abbreviations